157 related articles for article (PubMed ID: 10946019)
41. Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells.
Qin X; Tian J; Zhang P; Fan Y; Chen L; Guan Y; Fu Y; Zhu Y; Chien S; Wang N
Cardiovasc Res; 2007 Jun; 74(3):506-14. PubMed ID: 17368438
[TBL] [Abstract][Full Text] [Related]
42. Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats.
Dobashi K; Asayama K; Nakane T; Kodera K; Hayashibe H; Nakazawa S
Life Sci; 2000 Sep; 67(17):2093-101. PubMed ID: 11057759
[TBL] [Abstract][Full Text] [Related]
43. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
44. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
Ruan H; Pownall HJ; Lodish HF
J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648
[TBL] [Abstract][Full Text] [Related]
45. Regulation of stearoyl-CoA desaturase expression.
Ntambi JM; Miyazaki M; Dobrzyn A
Lipids; 2004 Nov; 39(11):1061-5. PubMed ID: 15726820
[TBL] [Abstract][Full Text] [Related]
46. Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase.
Kakuma T; Lee Y; Unger RH
Biochem Biophys Res Commun; 2002 Oct; 297(5):1259-63. PubMed ID: 12372423
[TBL] [Abstract][Full Text] [Related]
47. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
48. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
49. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S
J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of 3T3-L1 adipocyte differentiation by expression of acyl-CoA-binding protein antisense RNA.
Mandrup S; Sorensen RV; Helledie T; Nohr J; Baldursson T; Gram C; Knudsen J; Kristiansen K
J Biol Chem; 1998 Sep; 273(37):23897-903. PubMed ID: 9727003
[TBL] [Abstract][Full Text] [Related]
51. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
Albrektsen T; Fleckner J
Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452
[TBL] [Abstract][Full Text] [Related]
52. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes.
Hamm JK; Park BH; Farmer SR
J Biol Chem; 2001 May; 276(21):18464-71. PubMed ID: 11279134
[TBL] [Abstract][Full Text] [Related]
53. Glucose induces expression of stearoyl-CoA desaturase in 3T3-L1 adipocytes.
Jones BH; Standridge MK; Claycombe KJ; Smith PJ; Moustaïd-Moussa N
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):405-8. PubMed ID: 9867800
[TBL] [Abstract][Full Text] [Related]
54. Mechanism of adult primitive mesenchymal ST-13 preadipocyte differentiation.
Yajima Y; Sato M; Sumida M; Kawashima S
Endocrinology; 2003 Jun; 144(6):2559-65. PubMed ID: 12746319
[TBL] [Abstract][Full Text] [Related]
55. Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase.
Kobayashi J; Nagashima I; Hikita M; Bujo H; Takahashi K; Otabe M; Morisaki N; Saito Y
Br J Clin Pharmacol; 1999 Apr; 47(4):433-9. PubMed ID: 10233209
[TBL] [Abstract][Full Text] [Related]
56. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic β-cells by stearoyl-CoA desaturase and Elovl6.
Green CD; Olson LK
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E640-9. PubMed ID: 21266672
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-alpha.
Li Y; Totsune K; Takeda K; Furuyama K; Shibahara S; Takahashi K
Eur J Endocrinol; 2003 Sep; 149(3):231-8. PubMed ID: 12943526
[TBL] [Abstract][Full Text] [Related]
58. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
Perrey S; Ishibashi S; Yahagi N; Osuga J; Tozawa R; Yagyu H; Ohashi K; Gotoda T; Harada K; Chen Z; Iizuka Y; Shionoiri F; Yamada N
Metabolism; 2001 Jan; 50(1):36-40. PubMed ID: 11172472
[TBL] [Abstract][Full Text] [Related]
59. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
60. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
